News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Announces Thomas Schinecker as New President of 454 Life Sciences



7/14/2011 9:39:25 AM

BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a center of excellence of Roche’s (SIX: RO, ROG; OTCQX: RHHBY) business unit Applied Science, and developer of the innovative GS Junior and GS FLX+ Systems for high-throughput DNA sequencing, announced that effective August 1, 2011, Dr. Thomas Schinecker is appointed Lifecycle Leader for Sequencing and President of 454 Life Sciences, Inc., in Branford, Connecticut, USA, reporting to Robert Yates, Head of Applied Science.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES